Literature DB >> 3757529

Verapamil infusions in the treatment of atrial tachyarrhythmias.

R A Barbarash, J L Bauman, A A Lukazewski, J P Srebro, S Rich.   

Abstract

Ten patients with symptomatic atrial tachyarrhythmias were treated with an iv verapamil bolus (mean 8.5 mg) followed by a continuous verapamil infusion (mean dose 9.4 mg/h). The infusions were titrated to ventricular rate and continued for an average of 20 h, until oral therapy could be instituted. All patients had a significant, sustained reduction in ventricular rate during the infusion, without a significant reduction in mean arterial pressure. Although one patient complained of dizziness after 8 h of infusion therapy, the regimen was generally well tolerated and no patient had clinical worsening of heart failure. These preliminary data suggest that continuous verapamil infusions can safely and effectively control ventricular rate in patients with rapid atrial tachyarrhythmias, until oral medications can be started.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3757529     DOI: 10.1097/00003246-198610000-00011

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  2 in total

Review 1.  Prescribing trends and pharmacoeconomic considerations in the treatment of arrhythmias. Focus on atrial fibrillation and flutter.

Authors:  B G Phillips; J L Bauman
Journal:  Pharmacoeconomics       Date:  1995-06       Impact factor: 4.981

2.  The Safety and Efficacy of Verapamil Versus Diltiazem Continuous Infusion for Acute Rate Control of Atrial Fibrillation at an Academic Medical Center.

Authors:  Charlotte M Forshay; J Michael Boyd; Alan Rozycki; Jeffrey Pilz
Journal:  Hosp Pharm       Date:  2020-06-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.